In recent years, the medical world has witnessed a compelling shift towards the development of a new class of antibiotics aimed at tackling drug-resistant infections.As antibiotic resistance becomes a pressing public health crisis, driven by pathogens outsmarting our traditional treatments, innovative solutions are desperately needed.